We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Selenium Test Predicts Prostate Cancer

By HospiMedica staff writers
Posted on 20 Apr 2006
A new noninvasive test designed to detect prostate cancer measures the selenium content of clippings from a toenail.

If a man has too little selenium, he can supplement his diet. More...
If he has too much selenium, he can stop taking selenium supplements. Supplementation with selenium, a trace mineral and an essential nutrient found in a variety of foods, can reduce oxidative stress and genetic damage in the prostate. However, too little selenium can lead to undesirably high levels of DNA damage within the prostate.

The SeleniumHealth test is available from Bostwick Laboratories, Inc. (Richmond, VA, USA), an international diagnostic pathology laboratory, under license from the Gerald P. Murphy Cancer Foundation (Lafayette, IN, USA).

"This new test enables men to take an active role in reducing their personal cancer risk by paying attention to how much selenium they consume,” said David G. Bostwick, M.D., CEO, and CMO of Bostwick Laboratories. "Every man should know his baseline level before taking selenium as too little or too much may do more harm than good.”

When the relationship between selenium intake and the amount of DNA damage that had accumulated in the prostate were investigated, researchers found that the amount of DNA damage was most severe at the lowest and highest selenium intake, noted David J. Waters, D.V.M., Ph.D., director of the Gerald P. Murphy Cancer Foundation. "Clearly, more was not always better.”



Related Links:
Bostwick Labs

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.